The Claim

Multimodal screening using CA125 and transvaginal ultrasound results in 14 unnecessary surgeries per 10,000 screens, whereas ultrasound-only screening results in 50 unnecessary surgeries per 10,000 screens, thereby exposing women to greater avoidable surgical risks.

Source: Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
75score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

When doctors use both a blood test and an ultrasound to check for ovarian cancer, fewer women end up having unnecessary surgeries compared to using just the ultrasound — so the combo method is safer in that way.

See the scientific wording

Multimodal screening with CA125 and transvaginal ultrasound results in 14 unnecessary surgeries per 10,000 screens, while ultrasound-only screening results in 50 unnecessary surgeries per 10,000 screens, exposing women to avoidable surgical risks.

What the research says

1 study

  1. Study: Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

    The study found that using both a blood test and ultrasound to screen for ovarian cancer leads to far fewer unnecessary surgeries than using ultrasound alone — exactly what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.